One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception
- PMID: 28596121
- PMCID: PMC6040824
- DOI: 10.1016/j.contraception.2017.05.012
One-year continuation of copper or levonorgestrel intrauterine devices initiated at the time of emergency contraception
Abstract
Objective(s): This study compares 1-year intrauterine device (IUD) continuation among women presenting for emergency contraception (EC) and initiating the copper (Cu T380A) IUD or the levonorgestrel (LNG) 52 mg IUD plus 1.5 mg oral LNG.
Study design: This cohort study enrolled 188 women who presented at a single family planning clinic in Utah between June 2013 and September 2014 and selected either the Cu T380A IUD or LNG 52 mg IUD plus oral LNG for EC. Trained personnel followed participants by phone, text or e-mail for 12 months or until discontinuation occurred. We assessed reasons for discontinuation and used Cox proportional hazard models, Kaplan-Meier estimates and log-rank tests to assess differences in continuation rates between IUDs.
Results: One hundred seventy-six women received IUDs; 66 (37%) chose the Cu T380A IUD and 110 (63%) chose the LNG 52 mg IUD plus oral LNG. At 1 year, we accounted for 147 (84%) participants, 33 (22%) had requested removals, 13 (9%) had an expulsion and declined reinsertion, 3 (2%) had a pregnancy with their IUD in place and 98 (67%) were still using their device. Continuation rates did not differ by IUD type; 60% of Cu T380A IUD users and 70% of LNG 52 mg IUD plus oral LNG users were still using their device at 12 months (adjusted hazard ratio 0.72, 95% confidence interval 0.40-1.3).
Conclusion(s): Two-thirds of women who chose IUD placement at the EC clinical encounter continued use at 1 year. Women initiating Cu T380A IUD and LNG 52 mg IUD had similar 1-year continuation rates. These findings support same-day insertion of IUDs for women who are seeking EC and would like to use a highly effective reversible method going forward.
Implications: Providing IUD options for EC users presents an opportunity to increase availability of highly effective contraception.
Keywords: Continuation; Copper IUD; Emergency contraception; Levonorgestrel IUD.
Copyright © 2017. Published by Elsevier Inc.
Conflict of interest statement
Conflict of interest: D.K.T. receives speaking honoraria from Allergan, Medicines360, Merck and Teva. He serves on advisory boards for Actavis, Bayer, Pharmanest and Teva. The Department of Obstetrics and Gynecology, University of Utah, receives contraceptive clinical trials research funding from Bayer, Bioceptive, Contramed, Medicines360, Merck and Teva. L.M.G. reports personal fees from Evofem Medical Advisory Meeting, outside the submitted work.
Figures



Similar articles
-
One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.Am J Obstet Gynecol. 2023 Apr;228(4):438.e1-438.e10. doi: 10.1016/j.ajog.2022.11.1296. Epub 2022 Nov 23. Am J Obstet Gynecol. 2023. PMID: 36427600 Free PMC article. Clinical Trial.
-
Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.Contraception. 2016 Jun;93(6):526-32. doi: 10.1016/j.contraception.2016.01.009. Epub 2016 Mar 2. Contraception. 2016. PMID: 26944863 Free PMC article.
-
Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates.Contraception. 2014 Mar;89(3):222-8. doi: 10.1016/j.contraception.2013.11.010. Epub 2013 Nov 22. Contraception. 2014. PMID: 24332433 Free PMC article.
-
Progestin intrauterine devices versus copper intrauterine devices for emergency contraception.Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD013744. doi: 10.1002/14651858.CD013744.pub2. Cochrane Database Syst Rev. 2023. PMID: 36847591 Free PMC article.
-
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t. Contraception. 1991. PMID: 1773615 Review.
Cited by
-
One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial.Am J Obstet Gynecol. 2023 Apr;228(4):438.e1-438.e10. doi: 10.1016/j.ajog.2022.11.1296. Epub 2022 Nov 23. Am J Obstet Gynecol. 2023. PMID: 36427600 Free PMC article. Clinical Trial.
-
A Decision Analysis Model of 1-Year Effectiveness of Intended Postplacental Compared With Intended Delayed Postpartum Intrauterine Device Insertion.Obstet Gynecol. 2018 Nov;132(5):1211-1221. doi: 10.1097/AOG.0000000000002926. Obstet Gynecol. 2018. PMID: 30303909 Free PMC article.
-
Cost-effectiveness of emergency contraception options over 1 year.Am J Obstet Gynecol. 2018 May;218(5):508.e1-508.e9. doi: 10.1016/j.ajog.2018.01.025. Epub 2018 Feb 1. Am J Obstet Gynecol. 2018. PMID: 29409847 Free PMC article.
-
The intrauterine device as emergency contraception: how much do young women know?Contraception. 2018 Apr 18:S0010-7824(18)30145-8. doi: 10.1016/j.contraception.2018.04.009. Online ahead of print. Contraception. 2018. PMID: 29679591 Free PMC article.
-
The efficacy of intrauterine devices for emergency contraception and beyond: a systematic review update.Int J Womens Health. 2019 Aug 21;11:471-479. doi: 10.2147/IJWH.S213815. eCollection 2019. Int J Womens Health. 2019. PMID: 31686919 Free PMC article.
References
-
- Raymond EG, Trussell J, Polis CB. Population effect of increased access to emergency contraceptive pills: a systematic review. Obstet Gynecol. 2007;109:181–8. - PubMed
-
- Glasier A, Fairhurst K, Wyke S, Ziebland S, Seaman P, Walker J, et al. Advanced provision of emergency contraception does not reduce abortion rates. Contraception. 2004;69:361–6. - PubMed
-
- Polis CB, Schaffer K, Blanchard K, Glasier A, Harper CC, Grimes DA. Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol. 2007;110:1379–88. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources